Jung Sung Min, Kim Youn-Jung, Ryoo Seung Mok, Kim Won Young
Department of Emergency Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Acute Crit Care. 2019 May;34(2):141-147. doi: 10.4266/acc.2019.00465. Epub 2019 May 31.
Hemoglobin levels are a critical parameter for oxygen delivery in patients with shock. On comparing target hemoglobin levels upon transfusion initiation, the correlation between the severity of decrease in hemoglobin levels and patient outcomes remains unclear. We evaluated the association between initial hemoglobin levels and mortality in patients with septic shock treated with protocol-driven resuscitation bundle therapy at an emergency department.
Data of adult patients diagnosed with septic shock between June 2012 and December 2016 were extracted from a prospectively compiled septic shock registry at a single academic medical center. Patients were classified into four groups according to initial hemoglobin levels: ≥9.0 g/dl, 8.0-8.9 g/dl, 7.0-7.9 g/dl, and <7.0 g/dl. The primary endpoint was 90-day mortality.
In total, 2,265 patients (male, 58.3%; median age, 70.0 years [interquartile range, 60 to 78 years]) with septic shock were included. For the four groups, 90-day mortality rates were as follows: 29.1%, 43.0%, 46.5%, and 46.9% for ≥9.0 g/dl (n=1,808), 8.0-8.9 g/dl (n=217), 7.0-7.9 g/dl (n=135), and <7.0 g/dl (n=105), respectively (P<0.001). Multivariate logistic regression showed that initial hemoglobin levels were an independent factor associated with 90-day mortality and mortality proportionally increased with decreasing hemoglobin levels (odds ratio [OR], 1.88; 95% confidence interval [CI], 1.36 to 2.61 for 8.0-8.9 g/dl; OR, 1.97; 95% CI, 1.31 to 2.95 for 7.0-7.9 g/dl; and OR, 2.35; 95% CI, 1.52 to 3.63 for <7.0 g/dl).
Low hemoglobin levels (<9.0 g/dl) were observed in approximately 20% of patients with septic shock, and the severity of decrease in these levels correlated with mortality.
血红蛋白水平是休克患者氧输送的关键参数。在比较输血开始时的目标血红蛋白水平时,血红蛋白水平下降的严重程度与患者预后之间的相关性仍不明确。我们评估了急诊科接受方案驱动的复苏集束治疗的脓毒症休克患者初始血红蛋白水平与死亡率之间的关联。
从一个单一学术医学中心前瞻性编制的脓毒症休克登记处提取2012年6月至2016年12月期间诊断为脓毒症休克的成年患者的数据。根据初始血红蛋白水平将患者分为四组:≥9.0 g/dl、8.0 - 8.9 g/dl、7.0 - 7.9 g/dl和<7.0 g/dl。主要终点是90天死亡率。
总共纳入了2265例脓毒症休克患者(男性占58.3%;中位年龄70.0岁[四分位间距,60至78岁])。四组患者的90天死亡率如下:≥9.0 g/dl组(n = 1808)为29.1%,8.0 - 8.9 g/dl组(n = 217)为43.0%,7.0 - 7.9 g/dl组(n = 135)为46.5%,<7.0 g/dl组(n = 105)为46.9%(P < 0.001)。多因素逻辑回归显示,初始血红蛋白水平是与90天死亡率相关的独立因素,且死亡率随血红蛋白水平降低而呈比例增加(8.0 - 8.9 g/dl组的比值比[OR]为1.88;95%置信区间[CI]为1.36至2.61;7.0 - 7.9 g/dl组的OR为1.97;95% CI为1.31至2.95;<7.0 g/dl组的OR为2.35;95% CI为1.52至3.63)。
约20%的脓毒症休克患者观察到低血红蛋白水平(<9.0 g/dl),这些水平下降的严重程度与死亡率相关。